Cell-detection system promising for medical research, diagnostics

Oct 02, 2013 by Emil Venere
This schematic depicts a new system that uses tiny magnetic beads to quickly detect rare types of cancer cells circulating in a patient's blood, an advance that could help medical doctors diagnose cancer earlier than now possible and monitor how well a patient is responding to therapy. Credit: Purdue School of Mechanical Engineering image/ Bin-Da Chan

(Phys.org) —Researchers are developing a system that uses tiny magnetic beads to quickly detect rare types of cancer cells circulating in a patient's blood, an advance that could help medical doctors diagnose cancer earlier than now possible and monitor how well a patient is responding to therapy.

While other researchers have used for similar applications, the new "high-throughput" system has the ability to quickly process and analyze large volumes of blood or other fluids, said Cagri Savran (pronounced Chary Savran), an associate professor of mechanical engineering at Purdue University.

He is working with oncologists at the Indiana University School of Medicine to further develop the technology, which recently was highlighted in the journal Lab on a Chip.

The approach combines two techniques: immunomagnetic separation and microfluidics. In immunomagnetic separation, magnetic beads about a micron in diameter are "functionalized," or coated with antibodies that recognize and attach to antigens on the surface of .

The researchers functionalized the beads to recognize breast cancer and lung in laboratory cultures.

"We were able to detect cancer cells with up to a 90 percent yield," said Savran, working with Purdue postdoctoral fellow Chun-Li Chang and medical researchers Shadia Jalal and Daniela E. Matei from the IU School of Medicine's Department of Medicine. "We expect this system to be useful in a wide variety of settings, including detection of rare cells for clinical applications."

Previous systems using immunomagnetic separation to isolate cells required that the cells then be transferred to another system to be identified, counted and studied.

"What's new here is that we've built a system that can perform all of these steps on one chip," said Savran, also an associate professor of biomedical engineering. "It both separates cells and also places them on a chip surface so you can count them and study them with a microscope."

Another innovation is the fast processing, he said. Other "microfluidic" chips are unable to quickly process large volumes of fluid because they rely on extremely narrow channels, which restrict fluid flow.

"The circulating cancer cells are difficult to detect because very few of them are contained in blood," Savran said. "That means you have to use as many magnetic beads as practically possible to quickly screen and process a relatively large sample, or you won't find these cells."

The new design passes the fluid through a chamber that allows for faster flow; a standard 7.5-milliliter fluid sample can run through the system in a matter of minutes.

The Purdue portion of the research is based at the Birck Nanotechnology Center in Purdue's Discovery Park.

The beads are directed by a magnetic field to a silicon mesh containing holes 8 microns in diameter. Because the target cells are so sparse, many of the beads fail to attract any and pass through the silicon mesh. The beads that have attached to cells are too large to pass through the holes in the mesh.

If needed, the cells can quickly be flushed from the system for further analysis simply by turning off the .

"Not only can the cells be readily retrieved for further usage, the can be re-used for subsequent experiments," Savran said.

The technology also could be used to cull other types of .

"This is not only for cancer applications," he said.

The work has been supported by the Purdue Center for Cancer Research and the Purdue Oncological Sciences Center, the National Science Foundation and the Indiana University Melvin and Bren Simon Cancer Center.

Findings were detailed in a research paper published last year in Proceedings of IEEE Sensors. The work also was highlighted on Sept. 18 in Lab on a Chip.

Explore further: Capturing cancer: Liquid biopsy could improve cancer diagnosis and treatment

More information: Micro-Aperture Chip System for High-Throughput Immunomagnetic Cell Detection, dx.doi.org/10.1109/ICSENS.2012.6411336

ABSTRACT
We report a microchip system based on a combination of immunomagnetic separation and microfluidics for high-throughput detection of whole cells. In this system target cells bound to magnetic beads flow parallel to a microchip with flow rates of mLs/min. A magnetic field draws the bead-bound cells toward the microchip, which contains apertures that allow passage of unbound beads while trapping the target cells. The cells can be analyzed clearly under a microscope and released from the chip for further analysis by removing the magnetic field. The system was characterized by detecting breast cancer cells (MCF-7) and lung cancer cells (A549) in culture media using anti-EpCAM conjugated magnetic beads. We were able to detect MCF-7 cells with > 90% yield using a flow rate of about 4 mL/min, and A549 cells with 78% yield with 1 mL/min. We also demonstrated high-throughput detection of cells with concentrations as low as 0.8 cells/mL in large sample volumes (12 mL). We expect this system to be useful in a wide variety of settings, including detection of rare cells for clinical applications.

Related Stories

New detector for rare cancer cells

Jul 07, 2012

(Medical Xpress) -- Researchers in the US have developed a new detector for measuring rare circulating tumor cells (CTCs) in samples of whole blood.

Capturing live tumor cells in the blood

Aug 08, 2013

Tumor cells circulating within a patient's bloodstream can carry cancer from a primary tumor site to distant sites of the body, spreading the disease.

Capturing cancer cells

Feb 26, 2013

(Medical Xpress)—When dealing with cancer, time is critical. Identifying cancer before it spreads can often be the difference between life and death, so early diagnosis is key.

Technique filters cancer where chemo can't reach

Jul 30, 2013

(Medical Xpress)—A cancer therapy that removes malignant cells from a patient's cerebrospinal fluid may soon be available to prevent metastases and decrease complications of cancers involving the brain, according to Penn ...

Recommended for you

Science to the rescue of art

16 hours ago

Vincent van Gogh's "Sunflowers" are losing their yellow cheer and the unsettling apricot horizon in Edvard Munch's "The Scream" is turning a dull ivory.

Conjecture on the lateral growth of Type I collagen fibrils

Sep 12, 2014

Whatever the origin and condition of extraction of type I collagen fibrils, in vitro as well as in vivo, the radii of their circular circular cross sections stay distributed in a range going from 50 to 100 nm for the most ...

A dye with tunable optical characteristics

Sep 12, 2014

Researchers from RIKEN and the University of Tokyo have developed an organic dye molecule with tunable light-absorption and color characteristics. This development promises to open the door to the creation ...

User comments : 0